InFLAMES Flagship
- Rytmihäiriösairaudet (2024)
- Safety and immunogenicity of two Tau-targeting active immunotherapies, ACI-35.030 and JACI-35.054, in participants with early Alzheimer's disease: a phase 1b/2a, multicentre, double-blind, randomised, placebo-controlled study (2025)
- Salivary IL-33 and sST2 levels in relation to TLR2 rs111200466 polymorphism and periodontitis (2023)
- Salvage Magnetic Resonance Imaging–guided Transurethral Ultrasound Ablation for Localized Radiorecurrent Prostate Cancer (2025)
- Sappikivitauti ja sen komplikaatiot (2023)
- Sappikivitauti ja sen komplikaatiot (2024)
- Sappirakon ja maksan ulkoisten sappiteiden vammat (2024)
- SARS-CoV-2: No Increased Islet Autoimmunity or Type 1 Diabetes in Teens (2023)
- SARS-CoV-2 variants Alpha, Beta, Delta and Omicron show a slower host cell interferon response compared to an early pandemic variant (2022)
- Schizophrenia polygenic risk score and long-term success in the labour market: A cohort study (2022)





